skip to Main Content

Cancer Services

Breast Cancer

Name: GLORIA

A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High Risk, Early Stage Globo H-Positive Triple Negative Breast Cancer.

Principal Investigator: Dr Susan Tiley
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Breast Cancer
External page link More information about GLORIA study

Radiation Oncology clinical trials

Name: EXPERT

A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised luminal A early breast cancer (EXPERT)

Principal Investigator: Dr Hester Lieng
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Breast Cancer

External page link More Information about EXPERT

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top